Sigeon IP

Sigeon IP specializes in intellectual property protection, management, and commercialization for innovative technologies in the life sciences sector—including biotechnology, pharma, chemistry, medicine, veterinary science—offering comprehensive patent attorney and business advisory services to support R&D organizations from early-stage innovation through market entry.

The firm does not develop its own therapeutics but supports clients with patent filings/prosecution/litigation/validation in Poland/EU/globally as well as strategic advice on technology transfer and commercialization.

Their team includes professionals with strong scientific backgrounds across biological, chemical, medical fields.

They are active members of national/international professional organizations related to intellectual property.

The company operates globally but has its headquarters in Warsaw, Poland.

They are recognized by the Polish Investment and Trade Agency as part of the Polish biotech ecosystem.

No evidence found that they have been acquired or merged.

No evidence found of their own clinical pipeline or proprietary drug development.

No public trading symbol.

Key people include partners such as Grzelak.